orforglipron glp 1 Meet Orforglipron: A Pharmacist's Take on the New Oral GLP-1 Contender Orforglipron, an Oral Small-Molecule GLP-1

One of many more episodes to come on this hot topic

New research suggests that stopping GLP-1 drugs may raise risks of heart attack and stroke, complicating the booming weight loss trend.

A new solution with some downsides takes its place.

See which health clubs already do, plus the integration models, vendors, and compliance in the quarterly Inspire360 report.

Companies operating in this space may benefit from reviewing their promotional materials to ensure alignment with FDA expectations

A Re/Insurance View Of GLP-1s (Glucagon-Like Peptide 1 Receptor Agonists) October 2025 Share (3 Minute Read) Share this page Close